Show simple item record

Rituximab-induced hypogammaglobulinemia and intravenous immunoglobulin replacement therapy do not protect against relapse in granulomatous with polyangiitis

dc.contributor.authorBesada, Emilio
dc.date.accessioned2017-02-21T12:16:49Z
dc.date.available2017-02-21T12:16:49Z
dc.date.issued2016-08-10
dc.descriptionSource: <a href=http://dx.doi.org/10.1080/03009742.2016.1207299>doi: 10.1080/03009742.2016.1207299</a>en_US
dc.identifier.citationScandinavian Journal of Rheumatology. Supplement 2016, 45:48-48en_US
dc.identifier.cristinIDFRIDAID 1379335
dc.identifier.issn0301-3847
dc.identifier.urihttps://hdl.handle.net/10037/10323
dc.language.isoengen_US
dc.publisherTaylor & Francis Groupen_US
dc.rights.accessRightsopenAccessen_US
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759en_US
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759en_US
dc.titleRituximab-induced hypogammaglobulinemia and intravenous immunoglobulin replacement therapy do not protect against relapse in granulomatous with polyangiitisen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US


File(s) in this item

Thumbnail
Name:
article.pdf
Size:
195.0Kb
Format:
PDF
View/Open

This item appears in the following collection(s)

Show simple item record